Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis

Eleonora Virgilio, Domizia Vecchio, Ilaria Crespi, Roberto Serino, Roberto CANTELLO, Umberto DIANZANI, Cristoforo COMI

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Axonal loss is an important feature of Multiple Sclerosis (MS), being strongly related to irreversible disability accumulation. Nonetheless, the exact mechanisms underlying axonal loss remain unclear. Cerebrospinal fluid (CSF) levels of Tau and Beta-amyloid (Abeta) currently represent diagnostic biomarkers in other neurodegenerative diseases. In MS, studies on CSF Tau and Abeta provided preliminary informations on disease prognosis, but results have not yet been replicated.
Lingua originaleInglese
pagine (da-a)103231
RivistaMultiple Sclerosis and Related Disorders
Volume56
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • Amyloid beta-Peptides
  • Axons
  • Biomarker
  • Biomarkers
  • Humans
  • Magnetic Resonance Imaging
  • Multiple Sclerosis
  • Multiple sclerosis
  • Neurodegeneration
  • Prognosis
  • Tau
  • tau Proteins

Fingerprint

Entra nei temi di ricerca di 'Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis'. Insieme formano una fingerprint unica.

Cita questo